In this paper, two ferrocenyl–triphenyltin complexes were synthesized and characterized. Complex 2 is constructed as new multifunctional therapeutic platform for lysosome-targeted imaging and displayed much higher cytotoxicity than its analogue 1 by the introduction of a methyl group instead of a hydrogen atom in acylhydrazone. The cyclic voltammograms and reaction with GSH (glutathione) further confirmed that complex 1 has a reversible redox peak and can react with GSH, which indicate that complex 1 might lose its anticancer effect by undergoing reaction with GSH once it enters the cancer cell. Complex 2 could effectively catalyze the oxidation of NADH (the reduced form of nicotinamide adenine dinucleotide) to NAD+ and induce the productio...
Although current strategies for management of cancer have taken significant strides yet the outcome ...
Friedel–Crafts acylation of ferrocene with a biotin-derived carboxylic acid having 6-aminohexanoyl l...
We examined the effects of the ferrocene-based histone deacetylase-3 inhibitor Pojamide (N¹-(2-amino...
Earlier in vitro studies have shown that ferrocenyl amino acid and dipeptide bioconjugates exhibit a...
The development of new organometallic compounds as anticancer agents is currently an active area of ...
In this article, we report the findings of a comprehensive structure–activity relationship study of ...
Since the discovery of ferrocene in 1951 and subsequent structure elucidation in the following years...
Some iron chelators display significant anticancer activity that may involve ferritin degradation ei...
T cell acute lymphoblastic leukemia (T-ALL) is one of the most common causes of death in pediatric m...
Undesirable side effects of current cancer chemotherapeutic and multidrug resistance lead to an incr...
Herein we present a library of fully characterized beta-diketonate and beta-ketoiminate compounds th...
The successful design of antitumour drugs often combines in one molecule different biologically acti...
Despite the advances in early detection and targeted therapies, chemotherapy is still of vital impor...
Glutathione S-transferase GSTð has been one of the significant targets for cancer treatment in the p...
In the present study, we examined the cytotoxic effects of Schiff base complex, [N-(3,5-dichloro-2-o...
Although current strategies for management of cancer have taken significant strides yet the outcome ...
Friedel–Crafts acylation of ferrocene with a biotin-derived carboxylic acid having 6-aminohexanoyl l...
We examined the effects of the ferrocene-based histone deacetylase-3 inhibitor Pojamide (N¹-(2-amino...
Earlier in vitro studies have shown that ferrocenyl amino acid and dipeptide bioconjugates exhibit a...
The development of new organometallic compounds as anticancer agents is currently an active area of ...
In this article, we report the findings of a comprehensive structure–activity relationship study of ...
Since the discovery of ferrocene in 1951 and subsequent structure elucidation in the following years...
Some iron chelators display significant anticancer activity that may involve ferritin degradation ei...
T cell acute lymphoblastic leukemia (T-ALL) is one of the most common causes of death in pediatric m...
Undesirable side effects of current cancer chemotherapeutic and multidrug resistance lead to an incr...
Herein we present a library of fully characterized beta-diketonate and beta-ketoiminate compounds th...
The successful design of antitumour drugs often combines in one molecule different biologically acti...
Despite the advances in early detection and targeted therapies, chemotherapy is still of vital impor...
Glutathione S-transferase GSTð has been one of the significant targets for cancer treatment in the p...
In the present study, we examined the cytotoxic effects of Schiff base complex, [N-(3,5-dichloro-2-o...
Although current strategies for management of cancer have taken significant strides yet the outcome ...
Friedel–Crafts acylation of ferrocene with a biotin-derived carboxylic acid having 6-aminohexanoyl l...
We examined the effects of the ferrocene-based histone deacetylase-3 inhibitor Pojamide (N¹-(2-amino...